vs
微宏控股（MVST）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
微宏控股的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.3倍（$96.4M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -15.0%），微宏控股自由现金流更多（$15.8M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 8.9%）
微宏控股是一家电池科技企业，总部位于美国得克萨斯州斯塔福德，在纳斯达克上市。公司主要面向商用电动汽车与并网储能系统，设计、研发并生产电池组件及电池系统，目前在美国、中国、德国均设有生产基地。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MVST vs PBYI — 直观对比
营收规模更大
MVST
是对方的1.3倍
$75.5M
营收增速更快
PBYI
高出42.7%
-15.0%
自由现金流更多
MVST
多$1.4M
$14.4M
两年增速更快
PBYI
近两年复合增速
8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $96.4M | $75.5M |
| 净利润 | $16.5M | — |
| 毛利率 | 1.0% | 69.3% |
| 营业利润率 | -42.7% | 22.7% |
| 净利率 | 17.2% | — |
| 营收同比 | -15.0% | 27.7% |
| 净利润同比 | 120.1% | — |
| 每股收益（稀释后） | $0.19 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MVSTPBYI
| Q4 25 | $96.4M | $75.5M | ||
| Q3 25 | $123.3M | $54.5M | ||
| Q2 25 | $91.3M | $52.4M | ||
| Q1 25 | $116.5M | $46.0M | ||
| Q4 24 | $113.4M | $59.1M | ||
| Q3 24 | $101.4M | $80.5M | ||
| Q2 24 | $83.7M | $47.1M | ||
| Q1 24 | $81.4M | $43.8M |
净利润MVSTPBYI
| Q4 25 | $16.5M | — | ||
| Q3 25 | $-1.5M | $8.8M | ||
| Q2 25 | $-106.1M | $5.9M | ||
| Q1 25 | $61.8M | $3.0M | ||
| Q4 24 | $-82.3M | — | ||
| Q3 24 | $13.2M | $20.3M | ||
| Q2 24 | $-101.6M | $-4.5M | ||
| Q1 24 | $-24.8M | $-4.8M |
毛利率MVSTPBYI
| Q4 25 | 1.0% | 69.3% | ||
| Q3 25 | 37.6% | 77.7% | ||
| Q2 25 | 34.7% | 76.5% | ||
| Q1 25 | 36.9% | 77.1% | ||
| Q4 24 | 36.6% | 76.4% | ||
| Q3 24 | 33.2% | 63.9% | ||
| Q2 24 | 32.5% | 77.4% | ||
| Q1 24 | 21.2% | 75.5% |
营业利润率MVSTPBYI
| Q4 25 | -42.7% | 22.7% | ||
| Q3 25 | 10.5% | 17.6% | ||
| Q2 25 | 17.8% | 12.7% | ||
| Q1 25 | 16.3% | 8.7% | ||
| Q4 24 | -1.2% | 22.6% | ||
| Q3 24 | 7.1% | 27.4% | ||
| Q2 24 | -118.0% | -4.6% | ||
| Q1 24 | -28.4% | -5.3% |
净利率MVSTPBYI
| Q4 25 | 17.2% | — | ||
| Q3 25 | -1.2% | 16.2% | ||
| Q2 25 | -116.1% | 11.2% | ||
| Q1 25 | 53.0% | 6.5% | ||
| Q4 24 | -72.6% | — | ||
| Q3 24 | 13.1% | 25.2% | ||
| Q2 24 | -121.4% | -9.6% | ||
| Q1 24 | -30.5% | -11.0% |
每股收益（稀释后）MVSTPBYI
| Q4 25 | $0.19 | $0.26 | ||
| Q3 25 | $0.00 | $0.17 | ||
| Q2 25 | $-0.33 | $0.12 | ||
| Q1 25 | $0.05 | $0.06 | ||
| Q4 24 | $-0.24 | $0.40 | ||
| Q3 24 | $0.03 | $0.41 | ||
| Q2 24 | $-0.32 | $-0.09 | ||
| Q1 24 | $-0.08 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $105.0M | $97.5M |
| 总债务越低越好 | $13.2M | $22.7M |
| 股东权益账面价值 | $410.5M | $130.3M |
| 总资产 | $1.0B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.03× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MVSTPBYI
| Q4 25 | $105.0M | $97.5M | ||
| Q3 25 | $90.7M | $94.4M | ||
| Q2 25 | $99.7M | $96.0M | ||
| Q1 25 | $90.9M | $93.2M | ||
| Q4 24 | $73.0M | $101.0M | ||
| Q3 24 | $63.6M | $96.7M | ||
| Q2 24 | $68.2M | $96.8M | ||
| Q1 24 | $39.5M | $107.2M |
总债务MVSTPBYI
| Q4 25 | $13.2M | $22.7M | ||
| Q3 25 | $34.4M | $34.0M | ||
| Q2 25 | $34.2M | $45.3M | ||
| Q1 25 | $41.3M | $56.7M | ||
| Q4 24 | $41.1M | $68.0M | ||
| Q3 24 | $53.4M | $79.3M | ||
| Q2 24 | $34.2M | $90.7M | ||
| Q1 24 | $43.0M | $102.0M |
股东权益MVSTPBYI
| Q4 25 | $410.5M | $130.3M | ||
| Q3 25 | $358.1M | $115.3M | ||
| Q2 25 | $356.1M | $104.7M | ||
| Q1 25 | $454.2M | $97.1M | ||
| Q4 24 | $387.9M | $92.1M | ||
| Q3 24 | $486.1M | $71.1M | ||
| Q2 24 | $455.0M | $48.5M | ||
| Q1 24 | $546.1M | $51.0M |
总资产MVSTPBYI
| Q4 25 | $1.0B | $216.3M | ||
| Q3 25 | $1.0B | $202.9M | ||
| Q2 25 | $1.0B | $194.9M | ||
| Q1 25 | $982.9M | $196.2M | ||
| Q4 24 | $951.9M | $213.3M | ||
| Q3 24 | $997.9M | $220.7M | ||
| Q2 24 | $961.4M | $205.0M | ||
| Q1 24 | $1.0B | $214.1M |
负债/权益比MVSTPBYI
| Q4 25 | 0.03× | 0.17× | ||
| Q3 25 | 0.10× | 0.30× | ||
| Q2 25 | 0.10× | 0.43× | ||
| Q1 25 | 0.09× | 0.58× | ||
| Q4 24 | 0.11× | 0.74× | ||
| Q3 24 | 0.11× | 1.12× | ||
| Q2 24 | 0.08× | 1.87× | ||
| Q1 24 | 0.08× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $15.8M | $14.4M |
| 自由现金流率自由现金流/营收 | 16.4% | 19.1% |
| 资本支出强度资本支出/营收 | 0.7% | 0.0% |
| 现金转化率经营现金流/净利润 | 0.99× | — |
| 过去12个月自由现金流最近4个季度 | $56.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流MVSTPBYI
| Q4 25 | $16.4M | $14.4M | ||
| Q3 25 | $15.2M | $9.7M | ||
| Q2 25 | $37.2M | $14.1M | ||
| Q1 25 | $7.2M | $3.6M | ||
| Q4 24 | $6.1M | $15.6M | ||
| Q3 24 | $-5.4M | $11.0M | ||
| Q2 24 | $111.0K | $1.0M | ||
| Q1 24 | $2.0M | $11.2M |
自由现金流MVSTPBYI
| Q4 25 | $15.8M | $14.4M | ||
| Q3 25 | $1.2M | $9.7M | ||
| Q2 25 | $34.3M | $14.1M | ||
| Q1 25 | $4.8M | $3.6M | ||
| Q4 24 | $5.7M | $15.6M | ||
| Q3 24 | $-19.6M | $11.0M | ||
| Q2 24 | $-2.8M | $1.0M | ||
| Q1 24 | $-8.2M | — |
自由现金流率MVSTPBYI
| Q4 25 | 16.4% | 19.1% | ||
| Q3 25 | 1.0% | 17.7% | ||
| Q2 25 | 37.5% | 26.8% | ||
| Q1 25 | 4.1% | 7.7% | ||
| Q4 24 | 5.1% | 26.4% | ||
| Q3 24 | -19.3% | 13.7% | ||
| Q2 24 | -3.4% | 2.1% | ||
| Q1 24 | -10.1% | — |
资本支出强度MVSTPBYI
| Q4 25 | 0.7% | 0.0% | ||
| Q3 25 | 11.3% | 0.0% | ||
| Q2 25 | 3.1% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 14.0% | 0.0% | ||
| Q2 24 | 3.5% | 0.0% | ||
| Q1 24 | 12.6% | 0.0% |
现金转化率MVSTPBYI
| Q4 25 | 0.99× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | 0.12× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.41× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MVST
| Europe | $35.1M | 36% |
| CN | $32.5M | 34% |
| US | $21.5M | 22% |
| Other | $7.2M | 8% |
PBYI
暂无分部数据
